» Articles » PMID: 30233204

Natural Borneol is a Novel Chemosensitizer That Enhances Temozolomide-induced Anticancer Efficiency Against Human Glioma by Triggering Mitochondrial Dysfunction and Reactive Oxide Species-mediated Oxidative Damage

Overview
Publisher Dove Medical Press
Specialty Oncology
Date 2018 Sep 21
PMID 30233204
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Temozolomide (TMZ)-based chemotherapy represents an effective way for treating human glioma. However, its clinical application is limited because of its side effects and resistance to standard chemotherapy. Hence, the search for novel chemosensitizers to augment their anticancer efficiency has attracted much attention. Natural borneol (NB) has been identified as a potential chemosensitizer in treating human cancers. However, the synergistic effect and mechanism of NB and TMZ in human glioma have not been investigated yet.

Materials And Methods: U251 human glioma cells were cultured, and the cytotoxicity and apoptosis of NB and/or TMZ were examined by MTT assay, flow cytometric analysis and Western blot. Nude mice tumor model was also employed to evaluate the in vivo anticancer effect and mechanism.

Results: The results showed that the combined treatment of NB and TMZ more effectively inhibited human glioma growth via triggering mitochondria-mediated apoptosis in vitro, accompanied by the caspase activation. Combined treatment of NB and TMZ also caused mitochondrial dysfunction through disturbing Bcl-2 family expression. Further investigation revealed that NB enhanced TMZ-induced DNA damage through inducing reactive oxide species (ROS) overproduction. Moreover, glioma tumor xenograft growth in vivo was more effectively inhibited by the combined treatment with NB and TMZ through triggering apoptosis and anti-angiogenesis.

Conclusion: Taken together, our findings validated that the strategy of using NB and TMZ could be a highly efficient way to achieve anticancer synergism.

Citing Articles

An Update on Recent Drug Delivery Systems Targeting Brain Diseases via the Transnasal Pathway.

Zeng H, Lu H, Yang J, Hu P Pharm Res. 2024; 41(11):2121-2141.

PMID: 39477900 DOI: 10.1007/s11095-024-03790-3.


Characterization of Potential Target Genes of Borneol in Increasing Trastuzumab Sensitivity in HER2+ Trastuzumab-Resistant Breast Cancer: Bioinformatics and In Vitro Studies.

Lestari I, Rhamandana Putra I, Fatimah N, Ujiantari N, Pamungkas Putri D, Hermawan A Asian Pac J Cancer Prev. 2024; 25(5):1623-1634.

PMID: 38809634 PMC: 11318831. DOI: 10.31557/APJCP.2024.25.5.1623.


Bufotalin enhances apoptosis and TMZ chemosensitivity of glioblastoma cells by promoting mitochondrial dysfunction via AKT signaling pathway.

Zhu Z, Liang S, Hong Y, Qi Y, Sun Q, Zhu X Aging (Albany NY). 2024; 16(10):9264-9279.

PMID: 38809514 PMC: 11164496. DOI: 10.18632/aging.205883.


Baicalein as Promising Anticancer Agent: A Comprehensive Analysis on Molecular Mechanisms and Therapeutic Perspectives.

Morshed A, Paul S, Hossain A, Basak T, Hossain M, Hasan M Cancers (Basel). 2023; 15(7).

PMID: 37046789 PMC: 10093079. DOI: 10.3390/cancers15072128.


Interpreting the Therapeutic Efficiency of Multifunctional Hybrid Nanostructure against Glioblastoma.

Ou Z, Li X, You Y, Liu D, Wang J ACS Omega. 2023; 8(13):12259-12267.

PMID: 37033822 PMC: 10077551. DOI: 10.1021/acsomega.2c08265.


References
1.
Riedl S, Shi Y . Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol. 2004; 5(11):897-907. DOI: 10.1038/nrm1496. View

2.
Pelicano H, Carney D, Huang P . ROS stress in cancer cells and therapeutic implications. Drug Resist Updat. 2004; 7(2):97-110. DOI: 10.1016/j.drup.2004.01.004. View

3.
Chen J, Li L, Su J, Li B, Chen T, Wong Y . Synergistic apoptosis-inducing effects on A375 human melanoma cells of natural borneol and curcumin. PLoS One. 2014; 9(6):e101277. PMC: 4074168. DOI: 10.1371/journal.pone.0101277. View

4.
Shen Q, Li X, Li W, Zhao X . Enhanced intestinal absorption of daidzein by borneol/menthol eutectic mixture and microemulsion. AAPS PharmSciTech. 2011; 12(4):1044-9. PMC: 3225554. DOI: 10.1208/s12249-011-9672-4. View

5.
Martinou J, Youle R . Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev Cell. 2011; 21(1):92-101. PMC: 3156409. DOI: 10.1016/j.devcel.2011.06.017. View